BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc. is a biotechnology company focused on developing and commercializing therapies for rare genetic diseases, particularly enzyme replacement and gene therapies. Its portfolio includes approved treatments for conditions such as phenylketonuria (PKU), mucopolysaccharidosis, and other rare disorders.
Layoff history
EMPLOYEES AFFECTED PER QUARTER · HOVER FOR DETAILS
CONFIRMEDANNOUNCEDLayoff timeline
4 EVENTSBioMarin Pharmaceutical Inc. laid off 117 workers in California as part of a consolidation of its footprint. The article reports a specific reduction of 117 California employees tied to office/facility consolidation. No specific departments or exact effective date are provided in the text. The move is described as part of the company consolidating operations in the state, with no additional detail on severance, rehiring, or broader global cuts included.
Stories from here
No one has shared a story from BioMarin yet. Went through a layoff here? Your experience helps others feel less alone.
Share your story →Get alerts for BioMarin
We'll email you the moment a new layoff is reported here.